Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
Kurvi Patwala(Monash Health), Anouk Dev(Monash Medical Centre), Elizabeth Stratton(Liverpool Hospital), Zina Valaydon(The University of Melbourne), Stuart K. Roberts(The Alfred Hospital), Amanda Nicoll(The Royal Melbourne Hospital), Ashley Bloom(Eastern Health), Yael Celermajer(Royal Prince Alfred Hospital), Jessica Howell(The University of Melbourne), Paul Gow(The University of Melbourne), Eldho Paul(Monash Health), Siddharth Sood(The Royal Melbourne Hospital), Elise Murphy(The Royal Melbourne Hospital), David Prince(Liverpool Hospital), Geoffrey W. McCaughan(Royal Prince Alfred Hospital), Elliot Freeman(Alfred Health), Scott A. Davison(Liverpool Hospital), Marno Ryan(The University of Melbourne), Miriam Levy(Liverpool Hospital), McCawley Clark‐Dickson(Royal North Shore Hospital), Simone I. Strasser(University of Padua), Sally Bell(University of Glasgow), Ken Liu, Waafiqa Alam(Monash Health), Vi Nguyen(Royal North Shore Hospital), Alexandra Mack(Western Health), Alice Unah Lee(Concord Repatriation General Hospital)
Cited by 15
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
|New England Journal of Medicine|2017|565